Clinical Trial Update: Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update for palbociclib in combination with letrozole in postmenopausal women with HR+, HER2- advanced breast cancer; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2020-10-05